Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

6th Microbiome Movement - Drug Development Summit Europe

Evvnt Promotion / evvnt
-
25.01.2022 - 27.01.2022  The Tower Hotel, St Katharine's Way, E1W 1LD Greater London, England, United Kingdom
Time: 10:00 to 17:50
 
Temi della conferenza
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/919896-3?pid=4832

Speakers: Charles Bundinof, Strain Discovery and Microbiome Science Lead, IFF, Denise Kelly, Investment Advisor, Seventure, Duncan Peyton, CEO, 4D Pharma PLC, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/919896-2?pid=4832
Ms. Emily Lincoln
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developer - Conference Only: GBP 2049.00, Academic - Conference Only: GBP 1649.00, Solution and Service Provider - Conference Only: GBP 2699.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Ärzte der WeltCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarionewTreeHelix - Forschung & Beratung WienAlumni Club Medizinische Universität WienAMREF - African Medical and Research FoundationÖsterreichisches Rotes KreuzCharité International Academy